Contact Information
Company Information
Company
OncoArendi Therapeutics
Technologies
Outlook
Microsoft Office 365
Google Tag Manager
Mobile Friendly
Woo Commerce
reCAPTCHA
WordPress.org
Apache
MailChimp
YouTube
AI
Keywords
small molecule drug discovery
immunooncology
medicinal chemistry
pharmaceuticals
inflammatory diseases
fibrotic diseases
chitinase
arginase
respiratory diseases
cancer
immunotherapy
small molecule immunomodulators
biotechnology research
biotechnology
small molecule drugs
clinical trials
cancer therapies
first-in-class
chitinase inhibitors
arginase inhibitors
oatd-01
oatd-02
drug discovery
rna platform
protein targets
neoplastic diseases
fibrosis treatments
therapeutic development
pharmaceutical partnerships
clinical development
anti-inflammatory compounds
mrna targeting
immuno-oncology
therapeutic innovations
translational science
pulmonary sarcoidosis
idiopathic pulmonary fibrosis
metabolic diseases
exclusivity agreements
target identification
preclinical studies
research collaborations
undrugged targets
target validation
drug candidates
biopharmaceuticals
publicly traded
investor relations
research institutions
pipeline development
medical research
disease modulation
chronic diseases
biomarker discovery
phase i trials
phase ii trials
small molecule compounds
unexplored proteins
molecule design
drug efficacy
biotechnology competitive landscape
medical
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans